The AFR recently raised a red flag
The group’s history of operating disappointments has been punctuated by internal blues, with it going through four chief executives in less than 12 months over the period between 2013 and 2014.Despite attempting to commercialise its “wheeze test” for asthma for more than 10 years, it has yet to commercialise a product and reported the grand sum of $1000 in cash receipts for the three months to March 31.
Ann: Response to ASX Query, page-26
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
